Biomarker changes associated with Tuberculin Skin test (TST) conversion: A two-year longitudinal follow-up study in exposed household contacts

PLoS ONE

Volumn 4, Issue 10, 2009, Pages

  Hussain, Rabia ^a   Talat, Najeeha ^a   Shahid, Firdaus ^a   Dawood, Ghaffar ^b  

^a AGA KHAN UNIVERSITY   (Pakistan)

^b Masoomeen General Hospital   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 6; MITOGENIC AGENT; MYCOBACTERIUM ANTIGEN; TUMOR NECROSIS FACTOR ALPHA; BIOLOGICAL MARKER; CYTOKINE;

ADULT; ARTICLE; BLOOD CULTURE; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPOSURE; FEMALE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; SEROCONVERSION; TUBERCULIN TEST; COHORT ANALYSIS; FOLLOW UP; IMMUNE SYSTEM; IMMUNOLOGY; LUNG TUBERCULOSIS; METABOLISM; METHODOLOGY; PREVALENCE;

MYCOBACTERIUM TUBERCULOSIS;

ADULT; BIOLOGICAL MARKERS; COHORT STUDIES; CYTOKINES; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNE SYSTEM; INTERFERON-GAMMA; INTERLEUKIN-10; MALE; MYCOBACTERIUM TUBERCULOSIS; PREVALENCE; TUBERCULIN TEST; TUBERCULOSIS, PULMONARY;

EID: 70449338156     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0007444     Document Type: Article

References (43)

1. World Health Organization (2008) WHO Report 2008 - Country Profile Pakistan. Global Tuberculosis Control. pp 133-136.
2. Dye C, Scheele S, Dolin P, Nathanial V, Raviglione MC (1999) Global Burden of Tuberculosis: Estimated incidence, Prevalence, and Mortality by Country. JAMA 282: 677-686.
3. Hussain H, Akhtar S, Nanan D (2003) Prevalence of and risk factors associated with Mycobacterium tuberculosis infection in prisoners, North West Frontier Province, Pakistan. Int J Epidemiol 32: 794-799.
4. Rathi SK, Akhtar S, Rahbar MH, Azam SI (2002) Prevalence and risk factors associated with tuberculin skin test positivity among household contacts of smear-positive pulmonary tuberculosis cases in Umerkot, Pakistan. Int J Tuberc Lung Dis 6: 851-857.
5. Hussain R, Talat N, Shahid F, Dawood G (2007) Longitudinal tracking of cytokines after acute exposure to Tuberculosis: Association of Distinct Cytokine patterns with protection and disease development. Clin Vaccine Immunol 14: 1578-1586.
6. Akhtar S, White F, Hasan R, Rozi S, Younus M, et al. (2007) Hyperendemic pulmonary tuberculosis in peri-urban areas of Karachi, Pakistan. BMC Public Health 7: 70.
7. World Health Organization (2009) Review of National Immunization coverage 1980-2008 (Pakistan)..
8. Diel R, Nienhaus A, Lange C, Meywald-Walter K, Forssbohm M, et al. (2006) Tuberculosis contact investigation with a new, specific blood test in a low-incidence population containing a high proportion of BCG-vaccinated persons. Respir Res 7: 77.
9. Menzies D (1999) Interpretation of Repeated Tuberculin Tests. Am J Respir Crit Care Med 159: 15-21.
10. Sorensen AL, Nagai S, Houen G, Andersen P, Andersen AB (1995) Purification and characterization of a low-molecular mass 'T' cell antigen secreted by Mycobacterium tuberculosis. Infect Immun 63: 1710-1717.
11. Streeton JA, Desem N, Jones SL (1998) Sensitivity and specificity of a gamma interferon blood test for tuberculosis infection. Int J Tuberc Lung Dis 2: 443-450.
12. Britton W, Gilbert GL, Wheatley J, Leslie D, Rothel JS, et al. (2005) Sensitivity of human gamma interferon assay and tuberculin skin testing for detecting infection with Mycobacterium tuberculosis in patients with culture positive tuberculosis. Tuberculosis 85: 137-145.
13. Hill PC, Jackson-Sillah DJ, Fox a, Brookes RH, de Jong BC, et al. (2008) Incidence of tuberculosis and the predictive value of ELISPOT and Monteux tests in Gambian case contacts. PLoS ONE 3: e1379.
14. World Health Organization (2007) WHO: Global Tuberculosis Control: Surveillance, Planning, Financing.
15. Black GF, Fine PEM, Warndorff DK, Floyd S, Weir RE, et al. (2001) Relationship between IFN gamma and skin test responsiveness to Mycobacterium tuberculosis PPD in healthy, non BCG vaccinated young adults in Northern Malawi. Int J Tuberc Lung Dis 5: 1-9.
16. Kindler V, Sappino AP, Grau GE, Piguet PF, Via LE, et al. (1989) The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection. Cell 56: 731-740.
17. Keane J (2005) TNF-blocking agent and tuberculosis: new drugs illuminate an old topic. Rheumatology 44: 714-720.
18. Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O'Garra A (1991) IL-10 inhibits cytokine production by activated macrophages. J Immunol 147: 3815-3822.
19. O'Garra A, Vieira PL, Vieira P, Goldfeld AE (2004) IL-10 producing and naturally occurring CD4+ Tregs: limiting collateral damage. J Clin Invest 114: 1372-1378.
20. Abebe F, Mustafa T, Nerland AH, Bjune GA (2005) Cytokine profile during latent and slowly progressive primary tuberculosis: a possible role for interleukin-15 in mediating clinical disease. Clin Exp Immunol 143: 180-192.
21. Higgins DM, Sanchez-Campillo J, Rosas-Taraco AG, Lee EJ, Orme IM, et al. (2009) Lack of IL-10 alters inflammatory and immune responses during pulmonary Mycobacterium tuberculosis infection. Tuberculosis (Edinb) 89: 149-157.
22. Lue C, Kiyono H, McGhee JR, Fujihashi K, Kishimoti T, et al. (1991) Recombinant human interleukin 6 (rhIL-6) promotes the terminal differentiation of in vivo activated human B cells into antibody secreting cells. Cellular Immunology 132: 423-432.
23. Saunders BM, Frank AA, Orme IM, Cooper AM (2000) Interleukin-6 induces early gamma interferon production in the infected lung but is not required for generation of specific immunity to Mycobacterium tuberculosis infection. Infect Immun 68: 3322-3326.
24. Elliot AM, Hodsdon WS, Kyosiimire J, Quigley MA, Nakiyingi JS, et al. (2004) Cytokine responses and progression to active tuberculosis in HIV-1-infected Ugandans: a prospective study. Trans Roy Soc Trop Med & Hyg 98: 660-670.
25. Whalen CC, Chunda A, Zalwango S, Nshuti L, Jones-Lopez E, et al. (2006) Immune correlates of acute Mycobacterium tuberculosis infection in household contacts in Kampala Uganda. Am J Trop Med Hyg 75: 55-61.
26. Demissie A, Wassie L, Abebe M, Aseffa A, Rook G, et al. (2006) The 6 Kilodalton early secreted antigenic target-responsive, asymptomatic contacts of tuberculosis patients express elevated levels of interleukin-4 and reduced levels of gamma interferon. Infect Immun 74: 2817-2822.
27. Hill PC, Brookes RH, Fox A, Jackson-Sillah D, Jeffries DJ, et al. (2007) Longitudinal assessment of an ELISPOT test for Mycobacterium tuberculosis infection. PLoS Med 4: e192.
28. [Anonymous] (2009) World Health Organization statistics 2009.
29. Talat N, Shahid F, Dawood G, Hussain R (2009) Dynamic changes in Biomarker Profiles Associated with Clinical and Subclinical Tuberculosis in a High Transmission Setting: A Four-Year Follow-Study. Scand J Immunol 69: 537-546.
30. Crofton J (1990) Clinical features of tuberculosis. In: Seton D, Gordon A, eds. Crofton and Douglas Respiratory Diseases. London: Blackwell Scientific. pp 395-421.
31. Hussain R, Shiratsuchi H, Philips M, Ellner J, Wallis RS (2001) Opsonizing antibodies (IgG1) up-regulate monocyte proinflammatory cytokines tumor necrosis factor-alpha (TNF-α) and IL-6 but not anti-inflammatory cytokine IL-10 in mycobacterial antigen-stimulated monocytes-implications for pathogenesis. Clin Exp Immunol 123: 210-218.
32. Thakurdas SM, Hasan Z, Hussain R (2004) IgG1 antimycobacterial antibodies can reverse the inhibitory effect of pentoxifylline on tumour necrosis factor alpha (TNF-α) secreted by mycobacterial antigen stimulated adherent cells. Clin Exp Immunol 136: 320-327.
33. Hussain R, Kaleem A, Shahid F, Dojki M, Jamil B, et al. (2002) Cytokine profiles using whole blood assays can discriminate between tuberculosis patients and healthy endemic controls in BCG-vaccinated population. J Immunol Meth 264: 95-108.
34. Wallis RS, Amir-Tahmasseb M, Ellner JJ (1990) Induction of interleukin-1 and tumor necrosis factor by mycobacterial proteins: The monocyte western blot. Proc Natl Acad Sci USA 87: 3348-3352.
35. Wallis RS, Paranjape R, Philips M (1993) Identification of two dimensional Gel Electrophoresis of a 58-kilodalton tumor necrosis factor introducing protein of mycobacterium tuberculosis. Infect Immun 61: 627-632.
36. Gaikwad AN, Sinha S (2008) Determinants of natural immunity against tuberculosis in an endemic setting: factors operating at the level of macrophage-Mycobacterium tuberculosis interaction. Clin Exp Immunol 151: 414-422.
37. Ewer K, Millington KA, Deeks JJ, Alvarez L, Bryant G, et al. (2006) Dynamic antigen-specific T-cell responses after point-source exposure to Mycobacterium tuberculosis. Am J Respir Crit Care Med 174: 831-839.
38. Black GF, Weir RE, Chaguluka SD, Warndorff D, Crampin AC, et al. (2003) Gamma interferon responses induced by a panel of recombinant and purified mycobacterial antigens in healthy, non-Mycobacterium bovis BCG-vaccinated malawian young adults. Clin Diag Lab Immunol 10: 602-611.
39. Katakura T, Miyazaki M, Kobayashi M, Herndon DN, Suzuki F (2004) CCL17 and IL-10 as effectors that enable alternatively activated macrophages to inhibit the generation of classically activated macrophages. J Immunol 172: 1407-1413.
40. Stenger S, Modlin RL (2002) Control of Mycobacterium tuberculosis through mammalian Toll-like receptors. Curr Opin Immunol 14: 452-457.
41. Ito T, Schaller M, Hogaboam CM, Standiford TJ, Chensue SW, et al. (2007) TLR9 activation is a key event for the maintenance of a mycobacterial antigen-specific pulmonary granulomatous response. Eur J Immunol 37: 1-9.
42. Leal IS, Smedegard B, Andersen P, Appelberg R (1999) Interleukin-6 and interleukin-12 participate in induction of a type 1 protective T-cell response during vaccination with a tuberculosis subunit vaccine. Infect Immun 67: 5747-5754.
43. Young DB, Gideon HP, Wilkinson RJ (2009) Eliminating latent tuberculosis. Trends Microbiol 17: 183-188.